** J.P.Morgan upgrades beauty and skincare firm Bath & Body Works BBWI.N to "overweight" from "neutral", citing potential for revenue growth in FY25
** Brokerage sees BBWI's "three-legged stool" of product innovation, marketing and technology supporting growth within its "core" categories of home fragrance, body care, and hand soaps/sanitizers
** J.P.Morgan raises target price to $47 from $41, representing a ~29% upside from last close
** Brokerage says, "We see sales growth and therefore fixed cost leverage as the primary driver to bridge operating margins to management's ~20% long-term target"
** 13 of 19 brokerages rate the stock "buy" or higher, 5 "hold" and 1 "sell" or lower; their median PT is $45
** Up to last close, BBWI stock which fell 10% in 2024, was down 6% YTD in 2025
(Reporting by Kanchana Chakravarty in Bengaluru)
((Kanchana.Chakravarty@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。